You are here: Home >Archive for April, 2010

A New Application For Alogliptin / ACTOS (pioglitazone HCl)

Alogliptin (SYR-322)  drug is considered to be a member of the DPP-4 inhibitors class, which are newer oral agents for the treating diabetes (type 2 diabetes). The drug was discovered by Takeda’s wholly owned subsidiary, Takeda San Diego, Inc. By the way, Takeda is also the author of the thiazolidinedione (TZD) diabetes medication. The aim [...]

Tags: , , , ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

FDA Panel Decided To Keep Avandia (Rosiglitazone) On The Market

An oral drug generic Avandia is related to the thiazolidinedione class of diabetes drugs. Made by GlaxoSmithKline this drug is used by around 1 million Americans in treating diabetes to control their blood sugar. It has been known that yesterday an advisory committee to the federal agency voted to keep the Rosiglitazone diabetes on the [...]

Tags: , , ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

Effect Of Actos Diabetes On Cardiovascular Disease

It is known that such disease as type 2 diabetes is associated with a two- to four-fold increase in cardiovascular disease and also other cardiovascular risk factors, for example, cholesterol disorders and high blood pressure. Moreover, the main cause of mortality and morbidity for patients with type 2 diabetes is heart disease.

Tags: , , ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

Actual Data Of Safety In Use Of Generic Avandia (Rosiglitazone)

Avandia drug is related to the thiazolidinediones (TZD) class of medicines used in the treatment of Type 2 diabetes. Along with diet and exercise Rosiglitazone diabetes significantly improves blood sugar control.

Tags: , , ,

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS